
| Salt Composition: | Glimepiride (1mg) + Metformin (500mg) |
| Manufacturer: | Healthkind Labs Pvt Ltd |
| Storage: | Below 25 degree celcius |
Out of Stock
Have doubts about this medicine?
Have doubts about this medicine?
Glimwin-M1 Tablet ER is a combination of two medicines used to treat type 2 diabetes mellitus in adults, helping to control blood sugar levels. Glimwin-M1 Tablet ER belongs to a category of medicines known as anti-diabetic drugs. It is a combination of two medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Glimwin-M1 Tablet ER is a combination of two antidiabetic medicines: Glimepiride and Metformin. Glimepiride is a sulfonylurea which works by increasing the amount of insulin released by the pancreas in order to lower the blood glucose. Metformin is a biguanide which works by lowering glucose production in the liver, delaying glucose absorption from intestines and increasing the body's sensitivity to insulin.
What are the recommended storage conditions for Glimwin-M1 Tablet ER?
Store Glimwin-M1 Tablet ER in its original container, tightly closed, according to the instructions on the packaging. Dispose of any unused medication responsibly and keep it out of reach of children, pets, and other individuals.
Can the use of Glimwin-M1 Tablet ER lead to lactic acidosis?
Yes, the use of Glimwin-M1 Tablet ER can cause a rare but serious condition called metformin-associated lactic acidosis (MALA). This is characterized by increased levels of lactic acid in the blood and may occur more frequently in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain, weakness, dizziness, nausea, vomiting, abdominal pain, slow heart rate, and feeling cold in arms and legs. If you experience these symptoms, discontinue use and consult your doctor immediately.
What is Glimwin-M1 Tablet ER?
Glimwin-M1 Tablet ER is a combination medication containing glimepiride and metformin. It is used in the treatment of type 2 diabetes mellitus (DM) to improve blood glucose levels in adults when combined with a proper diet and regular exercise. Glimepiride works by increasing insulin release from the pancreas, while metformin reduces glucose production in the liver and improves insulin sensitivity.
What are the possible side effects of Glimwin-M1 Tablet ER?
Common side effects associated with the use of Glimwin-M1 Tablet ER include hypoglycemia (low blood sugar), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects may include lactic acidosis and Vitamin B12 deficiency on long-term use.
Can the use of Glimwin-M1 Tablet ER lead to Vitamin B12 deficiency?
Yes, the prolonged use of Glimwin-M1 Tablet ER can cause a deficiency in Vitamin B12. This may lead to anemia and nerve problems if left untreated, manifesting as tingling sensation and numbness in hands and feet, weakness, urinary issues, changes in mental status, and difficulty maintaining balance (ataxia). It is recommended that patients receive Vitamin B12 supplementation from outside sources at least once a year.
Can the use of Glimwin-M1 Tablet ER cause hypoglycemia?
Yes, the use of Glimwin-M1 Tablet ER can lead to low blood sugar levels (hypoglycemia). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feeling anxious or shaky. This risk is higher when missing or delaying meals, consuming alcohol, over-exercising, or taking other antidiabetic medications simultaneously.
Is it safe to take alcohol while I am also taking Glimwin-M1 Tablet ER?
No, it is not recommended to consume alcohol while using Glimwin-M1 Tablet ER as it can lower blood sugar levels and increase the risk of hypoglycemia and lactic acidosis.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Glimwin-M1 Tablet ER is to be taken with food.
Alcohol
It is unsafe to consume alcohol with Glimwin-M1 Tablet ER.
Breastfeed
Glimwin-M1 Tablet ER is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Pregnancy
Glimwin-M1 Tablet ER may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.